SCHEMBL5447338

SCHEMBL5447338

Cc1ccc(F)c(NC(=O)Nc2ccc(-n3cnc(C(N)=O)c3N)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 0.55
PDGFRB P09619 6/20 0.54
RAB9A P51151 3/20 0.52
NPC1 O15118 2/20 0.52
MAPT P10636 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
PKM P14618 1/20 0.52
FLT1 P17948 6/20 0.50
FLT4 P35916 6/20 0.50
FLT3 P36888 6/20 0.50
LCK P06239 5/20 0.50
BLK P51451 5/20 0.50
CSF1R P07333 5/20 0.50
KIT P10721 5/20 0.50
LYN P07948 4/20 0.50
ROCK2 O75116 3/20 0.50
AXL P30530 3/20 0.50
FRK P42685 3/20 0.50
CSNK1G2 P78368 3/20 0.50
ROCK1 Q13464 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5444130 0.87 KDR (0.57) KDRPDGFRBFLT1FLT4FLT3
SCHEMBL27652949 0.86 KDR (0.42) KDRPDGFRBRAB9ANPC1MAPT
SCHEMBL5447368 0.83 KDR (0.52) KDRPDGFRBSMN1; SMN2PKMFLT1
SCHEMBL5449198 0.80 CDK8 (0.53) KDRFLT1FLT4FLT3LCK
SCHEMBL4877916 0.77 ALDH1A1 (0.41) RAB9ANPC1MAPTSMN1; SMN2FGFR1
SCHEMBL12391453 0.77 ALDH1A1 (0.49) RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL5440740 0.76 RIPK1 (0.51) KDRMAPTSMN1; SMN2FLT1AURKB
SCHEMBL27673022 0.76 KDR (0.41) KDRRAB9ANPC1MAPTAURKB
SCHEMBL13499154 0.76 MAPK14 (0.70) MAPK13CDK8MAPK12EPHB4PTK2
SCHEMBL5439135 0.76 KDR (0.52) KDRPDGFRBFLT1FLT4FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225347-A1 Imidazole Derivatives MERCK PATENT GMBH (DE) 2007-09-27 US claimed
US-20070225347-A1 Imidazole Derivatives MERCK PATENT GMBH (DE) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225347-A1 Imidazole Derivatives TIE1, FLT1, FER KDR 4/4885PDGFRB 264/4885RAB9A 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.